Assessment of pharmacological hypothermia for acute ischemic stroke, focusing on mechanisms, mouse results, and translational challenges for humans.
Key Takeaways
- Two-drug combination induced hypothermia in mice by metabolic slowing and skin vasodilation
- Treated mice exhibited smaller brain infarcts and improved post-stroke neurological scores
- Human trial showed the drug regimen was safe but ineffective at tested doses